![](/img/cover-not-exists.png)
255PPhase 1 dose-escalation study of single-agent ZW25, a HER2-targeted bispecific antibody, in patients (pts) with HER2-expressing cancers
Beeram, M., Hamilton, E., Blum Murphy, M., Hausman, D., Infante, J.R., Korn, R., Patnaik, A., Piha-Paul, S.A., Rasco, D., Rowse, G., Thimmarayappa, J., Tolcher, A., Meric-Bernstam, F.Volume:
28
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdx365.018
Date:
September, 2017
File:
PDF, 48 KB
english, 2017